Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 49,844 | 48,580 | 0 | 0 | 0 |
| Cost of Goods | 38,954 | 38,378 | N/A | N/A | N/A |
| Gross Profit | 10,890 | 10,202 | N/A | N/A | N/A |
| Operating Expenses | 12,960 | 12,333 | 195,231 | 199 | 195 |
| Operating Income | -1,116 | -1,753 | -7,716 | -199 | -195 |
| Interest Expense | 81 | 101 | 0 | 0 | 0 |
| Other Income | 5,182 | 1,076 | -1,299 | -2,206 | -2,424 |
| Pre-tax Income | 3,985 | -778 | -9,015 | -2,404 | -2,619 |
| Income Tax | 780 | 218 | -506 | 13 | N/A |
| Net Income Continuous | 3,205 | -996 | -8,510 | -2,417 | -2,619 |
| Net Income | $3,205 | $-996 | $-8,510 | $-2,417 | $-2,619 |
| EPS Basic Total Ops | 0.05 | -0.02 | 0.45 | -0.08 | -0.46 |
| EPS Basic Continuous Ops | 0.05 | -0.02 | 0.78 | -0.42 | -0.46 |
| EPS Diluted Total Ops | 0.05 | -0.02 | 0.45 | -0.08 | -0.46 |
| EPS Diluted Continuous Ops | 0.05 | -0.02 | 0.78 | -0.42 | -0.46 |
| EBITDA(a) | $-305 | $-958 | $-195,231 | $-199 | $-195 |